Wird geladen...
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND AND OBJECTIVES: Revefenacin is a lung-selective, long-acting muscarinic antagonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease. The objectives of this analysis were to evaluate the pharmacokinetics of revefenacin and its major metabolite...
Gespeichert in:
| Veröffentlicht in: | Clin Pharmacokinet |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7932972/ https://ncbi.nlm.nih.gov/pubmed/33124005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00938-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|